| Literature DB >> 26742026 |
Hanqing Pang1, Liang Wu2, Yuping Tang3,4,5, Guisheng Zhou6, Cheng Qu7, Jin-ao Duan8,9,10.
Abstract
Radix Salviae miltiorrhizae et Rhizoma, known as Danshen in China, is one of the most popular traditional Chinese medicines. Recently, there has been increasing scientific attention on Danshen for its remarkable bioactivities, such as promoting blood circulation, removing blood stasis, and clearing away heat. This review summarized the advances in chemical analysis of Danshen and its preparations since 2009. Representative established methods were reviewed, including spectroscopy, thin layer chromatography, gas chromatography, liquid chromatography (LC), liquid chromatography-mass spectrometry (LC-MS), capillary electrophoresis, electrochemistry, and bioanalysis. Especially the analysis of polysaccharides in Danshen was discussed for the first time. Some proposals were also put forward to benefit quality control of Danshen.Entities:
Keywords: Danshen; chemical analysis; polysaccharides; quality control
Mesh:
Substances:
Year: 2016 PMID: 26742026 PMCID: PMC6273254 DOI: 10.3390/molecules21010051
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The Salvia miltiorrhiza Bunge (A) and the raw herb of S. miltiorrhiza Bunge (B).
Figure 2Phenolic acids in Radix Salviae miltiorrhizae.
Figure 3Terpene quinines in Radix Salviae miltiorrhizae.
LC methods of Danshen and Danshen-containing preparations.
| Detection Mode | Analytes | Sample | Stationary Phase | Mobile Phase | Qualitative or Quantitative Analysis | Reference |
|---|---|---|---|---|---|---|
| UHPLC/UV (280 nm) | Multi-components | Danshen herb | Waters Acquity UPLC BEN C18 (100 mm × 2.1 mm, 1.7 μm) | 10% 1,4-dioxane and 0.1% formic acid in water–10% 1,4-dioxane and 0.1% formic acid in acetonitrile (0 min: 100:0; 4 min: 80:20; 7 min: 50:50; 14 min: 100:0) | Qualitative analysis | [ |
| HPLC/DAD (270 nm) | DSS, PA, Sab, Cry, Tan IIA, Tan I | Compound preparations composed of Danshen and Gegen | Agilent Diamonsil C18 (200 mm × 4.6 mm, 5 μm) | 0.1% formic acid–acetonitrile (0 min: 80:20; 3 min: 78:22; 5 min: 70:30; 15 min: 35:65; 25 min: 30:70; 28 min: 30:70) | Quantitative analysis | [ |
| HPLC/UV (270 nm) | Dih, Cry, Tan I, Tan IIA, Mil | Danshen herb | Inertsil ODS-SP C18 (250 mm × 4.6 mm, 5μm) | Acetonitrile–0.2% acetic acid aqueous solution (55:45) | Quantitative analysis | [ |
| HPLC/UV (288 nm) | Sab | Danshen herb | Agilent Zorbax Eclipse XDB-C8 (150 mm × 4.6 mm, 5 μm) | 1% aqueous acetic acid–acetonitrile: methanol (3:2) (0 min: 75:25; 10 min: 65:35; 12 min: 75:25; 17 min: 75:25) | Qualitative analysis | [ |
| HPLC/DAD (190 to 400 nm) | Saa, Sab, RA, DSS, PA, Lit | Compound Danshen preparation | Agilent Extend C18 (250 mm × 4.6 mm, 5 μm) | Methanol–acetonitrile–tetrahydrofuran (10:90:0.05) with 50 mM phosphate buffer | Quantitative analysis | [ |
| HPLC/DAD (270 nm) | Multi-components | Danshen herb | Agilent Zorbax Extend C18 (250 mm × 4.6 mm, 5 μm) | Acetonitrile–0.02% phosphoric acid (0 min: 61:39; 6 min: 61:39; 18 min: 90:10; 18.5 min: 61:39; 23 min: 61:39) | Quantitative analysis | [ |
| HPLC/DAD (245, 262, 272 nm) | Tan I, Tan IIA, Cry | Danshen herb | Agilent Zorbax Eclipse C18 (150 mm × 4.6 mm, 3.5 μm) | Methanol–water (81:19) | Quantitative analysis | [ |
| HPLC/DAD (200 to 400 nm) | Saa, Sab, DSS | Danshen herb | Agilent TC-C18 (250 mm × 4.6 mm, 5 μm) | 0.05% phosphate–acetonitrile (0 min: 90:10; 15 min: 80:20; 35 min: 75:25; 45 min: 70:30; 55 min: 10:90; 70 min: 10:90) | Quantitative analysis | [ |
| HPLC/DAD (200 to 400 nm) | Cry, Dih, Tan I, Tan IIA, DSS, Sab | Danshen herb | Agilent Eclipse XDB-C18 (150 mm × 4.6 mm, 5 μm) | Water–acetonitrile (0 min: 45:55; 16 min: 45:55; 20 min: 20:80; 24 min: 20:80) | Quantitative analysis | [ |
| UHPLC/UV (281 nm) | DSS | Danshensu | Waters Acquity UPLC BEH C18 (50 mm × 2.1 mm; 1.7 μm) | Acetonitrile–0.1% formic acid water (0 min: 1:99; 7 min: 1:99: 12 min: 50:50; 14 min: 100:0; 15 min: 1:99) | Qualitative analysis | [ |
| UHPLC/DAD (254, 280 nm) | DSS, PA, CA, Dih, Tan I, Cry, Tan IIA | preparation Dan Lou tablet | Aglient Eclipse plus C18 (100 mm × 3.0 mm, 1.8 μm) | 0.1 % formic acid–acetonitrile (0 min: 90:10; 1 min: 85:15; 3 min: 78:22; 9 min: 70:30; 11 min: 34:66; 15 min: 34:66; 25 min: 20:80) | Qualitative analysis | [ |
| UHPLC/DAD (190 to 400 nm) | Multi-components | Compound Danshen tablets | Agilent Zorbax SB-C18 (100 mm × 4.6 mm, 1.8 μm) | 0.1% formic acid–acetonitrile (0 min: 95:5; 7 min: 83:17; 14 min: 75:25; 16 min: 72:28; 17 min: 70:30; 22 min: 45:55; 24 min: 29: 71; 27 min: 15:85; 35 min: 15:86) | Qualitative analysis | [ |
| UHPLC/DAD (190 to 400 nm) | Multi-components | Danshen herb | Phenomenex Kinetex HILIC column (50 mm × 4.6mm, 5 μm) | 10 mM ammonium acetate–acetonitrile (70:30) | Quantitative analysis | [ |
| HPLC/DAD (190 to 400 nm) | Multi-components | Guanxinning injection | Shiseido PC HILIC column (150 mm × 2 mm, 5 μm) | 10 mM ammonium formate containing 0.01% formic acid–acetonitrile (0 min: 8:92; 34 min: 28:72; 39 min: 40:60; 42 min: 8:92) | Qualitative analysis | [ |
| HPLC/DAD (270 nm) | Cry, Tan I, Tan IIA | Danshen herb | Diamons C18 (4.6 mm × 250 mm, 5 μm) | Water–77% methanol | Quantitative analysis | [ |
| HPLC/UV (280 nm) | Cry, DSS, PA, PD, Tan I, Tan IIA, Sal B, Dih | Danshen herb | Waters SunFire RP-18 (150 mm × 3 mm, 3.5 μm) | Water–acetonitrile both with 0.1% formic acid (0 min: 50:50; 30 min: 100:0; 35 min: 100:0) | Quantitative analysis | [ |
| HPLC-ED (−0.4 V) | Cry, Tan I, Tan IIA | Danshen herb | Capcell Pak C18 (150 mm × 1.0 mm, 3 μm) | Acetonitrile–water–formic acid (52:48:0.6) | Quantitative analysis | [ |
| HPLC/DAD (254, 280 nm) | Sab, Dih, Cry, Tan I, Tan IIA | Danshen herb | Kinetex core-shell C18 (100 × 4.6 mm, 2.6 μm) | 0.1% trifluoroacetic acid aqueous–acetonitrile (0 min: 93:7; 10 min: 78:22; 20 min: 67:33; 28 min: 48:52; 31 min: 35:65; 36 min: 19:81) | Quantitative analysis | [ |
| HPLC-UV (190 to 400 nm) | DSS, CA, Sab, Sac, RA, PA, Cry, Tan I, Tan IIA | Danshen herb | Merck RP-18e (100 mm × 4.6 mm, 2 μm) | Brij35–cyclohexane–phosphate buffer (pH = 6.60)– | Qualitative analysis | [ |
| UHPLC/PDA (280 nm) | Sab, RA, Cry, Tan I, Tan IIA, PA, PD, CA, Fer, I-Fer, Saa, Dih, Prz | Danshen herb | Waters Acquity UPLC BEH C18 (50 mm × 2.1 mm, 1.7 μm) | 0.5% Phosphoric acid–acetonitrile (0 min: 95:5; 0.5 min: 90:10; 6 min: 77:23; 7.8 min: 70:30; 9.0 min: 58:42; 11.5 min: 55:45; 14.5 min: 54:46; 17.5 min: 15:85) | Quantitative analysis | [ |
| HPLC/DAD (280 nm) | DSS, Sab, PD, Tan IIA, Cry | Danshen herb | Waters SunFire RP-18 (3.0 × 150 mm, 3.5μm) | Water–acetonitrile both with 0.1% formic acid (0 min: 50:50; 30 min: 100:0; 35 min: 100:0) | Qualitative analysis | [ |
| HPLC/DAD (280 nm) | DSS, PA, PD, CA, RA, LA, Sab, Saa, Sac, Dih, Cry, Tan I, Tan IIA | Danshen herb | KinetexTM C18 (100 mm × 4.6 mm, 2.6 μm) | 0.1% aqueous TFA–acetonitrile (0 min: 93:7; 4 min: 82:18; 15 min: 76:24; 20 min: 67:33; 28 min: 48:52) | Quantitative analysis | [ |
| HPLC/UV (280 nm) | Saa, Sab, PD, Cry, Tan I, Tan IIA | Danshen herb | Agilent reversed phase XDB C18 (250 mm × 4.6 mm, 5 μm) | 0.1% aqueous phosphoric acid–acetonitrile (0 min: 98:2; 20 min: 83:17; 60 min: 32:28; 70 min: 26:74; 88 min: 70:30; 100 min: 98:2) | Quantitative analysis | [ |
| HPLC/DAD (190 to 500 nm) | DSS, PA, RA, Sab, Dih, Tan I, Cry, Tan IIA | Danshen herb | Agilent Zorbax SB-C18 (150 mm × 4.6 mm, 5 μm) | Methanol–water containing 0.5% acetic acid (0 min: 20:80; 10 min: 35:65; 20 min: 40:60; 40 min: 70:30; 50 min: 80:20) | Quantitative analysis | [ |
| HPLC/DAD (190 to 500 nm) | Fingerprint analysis | Danshen herb | Waters SunFire C18 (250 mm × 4.6 mm, 5 μm) | Methanol–water (0 min: 60:40; 25 min: 70:30; 35 min: 75:25; 45 min: 90:10; 55 min: 100:0) | Qualitative analysis | [ |
| HPLC/DAD (270, 288 nm) | Fingerprint analysis | Danshen herb | Symmetry C18 (250 mm × 4.6 mm, 5 μm) | methanol–water (56:44) for ether extract; 0.5 % formic acid–methanol (0 min: 80:20; 10 min: 60:40; 30 min: 60:40; 45 min: 40:60) | Qualitative analysis | [ |
| UHPLC/PDA (280 nm) | Fingerprint analysis | Danshen herb | Waters Acquity UPLC BEH C18 (50 mm × 2.1 mm, 1.7 μm) | 0.026% phosphoric acid–acetonitrile (0 min: 85:15; 5 min: 75:25; 8 min: 70:30; 12 min: 50:50; 17 min:10:90) | Qualitative analysis | [ |
| HPLC/DAD (200 to 400 nm) | Fingerprint analysis | compound Danshen tablet | Agilent XDB-C18 (150 mm × 4.6 mm, 5 μm) | Methanol–water (73:27) | Qualitative analysis | [ |
| HPLC/DAD (190 to 400 nm) | Fingerprint analysis | Danshen Injection | Zorbax Extend C18 (250 mm × 4.6 mm, 5 μm) | 0.5% formic acid–acetonitrile (0 min: 90:10; 12 min: 78:22; 30 min: 70:30; 38 min: 55:45; 45 min: 10:90; 50 min: 10:90) | Qualitative analysis | [ |
Note: Saa, (salvianolic acid A); Sab, (salvianolic acid B); Sac, (salvianolic acid C); DSS, (danshensu); RA, (rosmarinic acid); LA, (lithospermic acid); CA, (caffeic acid); PA, (protocatechuic acid); PD, (protocatechualdehyde); Fer, (ferulic acid); I-Fer, (I-ferulic acid); Tan I, (tanshinone I); Tan IIA, (tanshinone IIA); Cry, (cryptotanshinone); Dih, (dihydrotanshinone); Prz, (przewalskin).